These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6401383)

  • 1. Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Evidence of hypothalamic dysfunction.
    Chung KF; Alaghband-Zadeh J; Guz A
    Am J Dis Child; 1983 Feb; 137(2):134-6. PubMed ID: 6401383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome.
    Cuttler L; Jackson JA; Saeed uz-Zafar M; Levitsky LL; Mellinger RC; Frohman LA
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1148-54. PubMed ID: 2498385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The McCune-Albright syndrome.
    Mauras N; Blizzard RM
    Acta Endocrinol Suppl (Copenh); 1986; 279():207-17. PubMed ID: 3465162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian function in girls with McCune-Albright syndrome.
    Foster CM; Feuillan P; Padmanabhan V; Pescovitz OH; Beitins IZ; Comite F; Shawker TH; Loriaux DL; Cutler GB
    Pediatr Res; 1986 Sep; 20(9):859-63. PubMed ID: 3092175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal hypothalamic-pituitary function in polyostotic fibrous dysplasia.
    Albin J; Wu R
    Clin Endocrinol (Oxf); 1981 May; 14(5):435-43. PubMed ID: 6796294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995--bromocriptine combined treatment results.
    Cremonini N; Graziano E; Chiarini V; Sforza A; Zampa GA
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1166-9. PubMed ID: 1400888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Albright syndrome associated with acromegaly: report of a case and review of the literature.
    Lipson A; Hsu TH
    Johns Hopkins Med J; 1981 Jul; 149(1):10-4. PubMed ID: 7019531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. A histologic, immunocytologic and ultrastructural study of the surgically-removed adenohypophysis.
    Kovacs K; Horvath E; Thorner MO; Rogol AD
    Virchows Arch A Pathol Anat Histopathol; 1984; 403(1):77-86. PubMed ID: 6426154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomous ovarian hyperfunction followed by gonadotrophin-dependent puberty in McCune-Albright syndrome.
    Kaufman FR; Costin G; Reid BS
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):239-42. PubMed ID: 3085997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia. A variant of the McCune-Albright syndrome.
    Abs R; Beckers A; Van de Vyver FL; De Schepper A; Stevenaert A; Hennen G
    J Endocrinol Invest; 1990 Sep; 13(8):671-5. PubMed ID: 2273209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone excess and sexual precocity in polyostotic fibrous dysplasia (McCune-Albright syndrome): evidence for abnormal hypothalamic function.
    Lightner ES; Penny R; Frasier SD
    J Pediatr; 1975 Dec; 87(6 Pt 1):922-7. PubMed ID: 1185394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (Mc Cune--Albright syndrome).
    Polychronakos C; Tsoukas G; Ducharme JR; Letarte J; Collu R
    J Endocrinol Invest; 1982; 5(5):323-6. PubMed ID: 7153476
    [No Abstract]   [Full Text] [Related]  

  • 14. McCune-Albright syndrome: evidence for autonomous multiendocrine hyperfunction.
    D'Armiento M; Reda G; Camagna A; Tardella L
    J Pediatr; 1983 Apr; 102(4):584-6. PubMed ID: 6403689
    [No Abstract]   [Full Text] [Related]  

  • 15. McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases.
    Chanson P; Dib A; Visot A; Derome PJ
    Eur J Endocrinol; 1994 Sep; 131(3):229-34. PubMed ID: 7921205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune-Albright syndrome.
    Comite F; Shawker TH; Pescovitz OH; Loriaux DL; Cutler GB
    N Engl J Med; 1984 Oct; 311(16):1032-6. PubMed ID: 6434946
    [No Abstract]   [Full Text] [Related]  

  • 17. Acromegaly and its treatment in the McCune-Albright syndrome.
    Premawardhana LD; Vora JP; Mills R; Scanlon MF
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):605-8. PubMed ID: 1424186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyostotic fibrous dysplasia with acromegaly.
    Harris RI
    Am J Med; 1985 Mar; 78(3):539-42. PubMed ID: 3976710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.
    Sherman SI; Ladenson PW
    J Endocrinol Invest; 1992 Mar; 15(3):185-90. PubMed ID: 1624678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.